| 1 |
Collins FS, Varmus H. A new initiative on precision medicine [J]. N Engl J Med, 2015, 372(9): 793-795.
|
| 2 |
Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis [J]. JAMA, 2010, 304(16): 1787-1794.
|
| 3 |
Singer IM, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
|
| 4 |
Angus DC, Linde-zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [J]. Crit Care Med, 2001, 29(7): 1303-1310.
|
| 5 |
Head LW, Coopersmith CM. Evolution of sepsis management: from early goal-directed therapy to personalized care [J]. Adv Surg, 2016, 50(1): 221-234.
|
| 6 |
Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy [J]. J Intensive Care, 2017, 5: 51-57.
|
| 7 |
Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal [J]. Critical Care, 2020, 24(1): 287-301.
|
| 8 |
JäMSä J, Ala-Kokko T, Huotari V, et al. Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities [J]. J Crit Care, 2018, 43:139-142.
|
| 9 |
Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research [J]. Lancet Infect Dis, 2015, 15(5), 581-614.
|
| 10 |
苏磊,徐秋林. 精准医学时代的脓毒症研究 [J]. 中华急诊医学杂志, 2016, 25(2): 133-138.
|
| 11 |
Fatani SH, Alkhatib KH, Badr H, et al. Association of TNF-α-308 (G ＞A) (rs1800629) gene polymorphism with adverse outcomes of sepsis in critically ill patients [J]. DNA Cell Biol, 2020, 39(9): 1723-1729.
|
| 12 |
Wu Q, Xu X, Ren J, et al. Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis [J]. BMC Anesthesiol, 2017, 17(1): 11.
|
| 13 |
Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults [J]. Crit Care Med, 2005, 33(3): 638-644.
|
| 14 |
Yende S, Angus DC, Kong L, et al. The influence of maemphage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia [J]. FASEB J, 2009, 23(8): 2403-2411.
|
| 15 |
Flores C, Ma SF, Maresso K, et al. IL6 gene-wide haplotype is associated with susceptibility to acute lung injury [J]. Transl Res, 2008, 152(1): 11-17.
|
| 16 |
Sutherland AM, Walley KR, Manocha S, et al. The association of interleukin 6 haplotype clades with mortality in critically ill adults [J]. Arch Intern Med, 2005, 165(1): 75-82.
|
| 17 |
Chen QX, Wu SJ, Wang HH, et al. Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population [J]. Hum Genet, 2008, 123(3): 281-287.
|
| 18 |
Russell JA, Wellman H, Walley KR. Protein C rs2069912 C allele is associated with increased mortality from severe sepsis in North Americans of East Asian ancestry [J]. Hum Genet, 2008, 123(6): 661-663.
|
| 19 |
Pachot A, Cazalis MA, Venet F, et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression [J]. J Immunol, 2008, 180(9): 6421-6429.
|
| 20 |
Johnson SB, Lissauer M, Bochicchio GV, et al. Gene expression profiles differentiate between sterile SIRS and early sepsis [J]. Ann Surg, 2007, 245(4): 611-621.
|
| 21 |
Liu L, Ning B. The role of MBL2 gene polymorphism in sepsis incidence [J]. Int J Clin Exp Pathol, 2015, 8(11): 15123-15127.
|
| 22 |
Middleton EA, Rowley JW, Campbell RA, et al. Sepsis alters the transcriptional and translational landscape of human and murine platelets [J]. Blood, 2019, 134(12): 911-923.
|
| 23 |
刘大为, 王小亭, 张宏民, 等. 重症血流动力学治疗-北京共识 [J]. 中华内科杂志, 2015, 54(3): 248-271.
|
| 24 |
王小亭, 刘大为, 张宏民, 等. 扩展的目标导向超声心动图方案对感染性休克患者的影响 [J]. 中华医学杂志, 201l, 91(27):1879-1883.
|
| 25 |
沈延飞, 蔡国龙. 脓毒症相关微循环障碍的研究进展 [J/OL]. 中华重症医学电子杂志, 2020, 6(2): 160-164.
|
| 26 |
Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis [J]. JAMA, 2019, 321(20): 2003-2017.
|
| 27 |
Roberts JA, Abdul-aziz MH, Lipman J. etal. Individualised antibiotic dosing for patients who are criticalill: challengs and potential solutions [J] Lancet Infect Dis, 2014, 14(6): 498-509.
|
| 28 |
黄英姿, 邱海波. 药代动力学导向的重症感染患者抗生素个体化与精准化治疗 [J]. 中华内科杂志, 2016, 55(6): 425-427.
|
| 29 |
Jiwaji Z, Brady S, Mcintyre LA, et al. Emergency department management of early sepsis: a national survey of emergency medicine and intensive care consultants [J]. Emerg Med J, 2014, 31(12): 1000-1005.
|
| 30 |
Spyridaki A, Raftogiannis M, Antonopoulou A, et al. Effect of elarithromycin in inflammatory inarkers of patients with ventilator-associated pneumonia and sepsis caused by gram-negative bacteria: Results from a randomized clinical study [J]. Antimicrob Agents Chemother, 2012, 56(7): 3819-3825.
|
| 31 |
Savva A, Kanni T, Damoraki G, et al. Impact of toll-like receptor-4 and turnout necrosis factor gene polymorphisms in patients with hidradenitis suppurativa [J]. Br J Dermatol, 2013, 168(2): 311-317.
|
| 32 |
肖桂珍, 李俊, 苏磊. 危重患者的精准营养 [J]. 中华危重病急救医学, 2017, 29(11): 1052-1056.
|
| 33 |
Committee on a Framework for Development a New Taxonomy of Disease, National Research Council. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease [M]. National Academies Press (US), 2011.
|
| 34 |
Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs [J]. JAMA. 2014, 311(19): 1998-2006.
|